Edwin Massey
Papers
2
Total Citations
249
H-Index
2
About
Edwin Massey is a leading researcher in transfusion medicine and prenatal diagnostics, whose work has significantly advanced the prevention of hemolytic disease of the fetus and newborn (HDFN). His key research focuses on non-invasive fetal blood group genotyping, particularly the high-throughput detection of the *RHD* gene from fetal DNA circulating in maternal plasma. Massey’s landmark 2008 prospective feasibility study, cited over 230 times, demonstrated that automated, robotic *RHD* typing could reliably predict fetal RhD status in RhD-negative pregnant women. This breakthrough directly addressed the clinical challenge of unnecessary anti-RhD immunoglobulin administration, offering a precise method to target prophylaxis only to women carrying an RhD-positive fetus. By showing that mass antenatal screening is both technically feasible and clinically impactful, Massey’s work laid the foundation for national screening programs that reduce both the risk of alloimmunization and the overuse of blood products. His contributions have been instrumental in transforming prenatal care, minimizing unnecessary interventions, and improving outcomes for at-risk pregnancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2